Insider · CIK 0001251956
David J Matlin
director
Files at CLNN (Clene Inc.), TLSI (TriSalus Life Sciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | CLNN Clene Inc. | AGrant or award common stock | +434,451 | $3.28 | $1.4M | 912,275 | 24 d ago |
| Aug 14, 2025 | CLNN Clene Inc. | AGrant or award stock optionderivative | +7,255 | $0.00 | $0 | 7,255 | Aug 15, 2025 |
| Jun 12, 2025 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 65,000 | Jun 27, 2025 |
| May 22, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +10,209 | $0.00 | $0 | 10,209 | May 23, 2025 |
| May 22, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,500 | $0.00 | $0 | 1,500 | May 23, 2025 |
| Feb 27, 2025 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +5,628 | $0.00 | $0 | 5,628 | Feb 28, 2025 |
| Dec 6, 2024 | CLNN Clene Inc. | AGrant or award Stock Options (Right to buy)derivative | +5,563 | $0.00 | $0 | 5,563 | Dec 9, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.